Amdocs (NASDAQ:DOX – Get Free Report) updated its FY 2025 earnings guidance on Tuesday. The company provided EPS guidance of 6.859-7.116 for the period, compared to the consensus EPS estimate of 6.440. The company issued revenue guidance of $4.5 billion-$4.6 billion, compared to the consensus revenue estimate of $5.0 billion. Amdocs also updated its FY25 guidance to $6.86-7.12 EPS.
Wall Street Analyst Weigh In
DOX has been the topic of a number of recent analyst reports. Oppenheimer increased their price objective on shares of Amdocs from $98.00 to $105.00 and gave the stock an “outperform” rating in a research report on Wednesday. StockNews.com raised Amdocs from a “buy” rating to a “strong-buy” rating in a research note on Friday, October 25th. Finally, Stifel Nicolaus started coverage on Amdocs in a research report on Wednesday, October 2nd. They issued a “buy” rating and a $100.00 price objective on the stock. One analyst has rated the stock with a hold rating, five have given a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, Amdocs currently has an average rating of “Buy” and a consensus price target of $102.50.
Read Our Latest Analysis on DOX
Amdocs Stock Down 5.4 %
Amdocs Company Profile
Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.
Featured Articles
- Five stocks we like better than Amdocs
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Can United States Cellular Ride Higher on Its Spectrum Strategy?
- Best ESG Stocks: 11 Best Stocks for ESG Investing
- HubSpot’s Growth in CRM: Can It Compete With Salesforce?
- 3 REITs to Buy and Hold for the Long Term
- Neurogene Stock Plummets 44%: Is All Hope Lost for This Biotech?”
Receive News & Ratings for Amdocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs and related companies with MarketBeat.com's FREE daily email newsletter.